Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen L Gabrielson

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|March 8, 2007
Spontaneous lesions in the reproductive tract and mammary gland of female non-human primatesTimothy K Cooper, Kathleen L Gabrielson
Comparative Medicine|September 16, 2022
Canine Idiopathic Arteriopathy, Appendicular Bone Infarcts, and Neoplastic Transformation of Bone Infarcts in 108 Dogs (<i>Canis lupus familiaris</i>)Isabel A Jimenez, Roy R Pool, Kathleen L Gabrielson
Toxicologic Pathology|May 10, 2022
The Common Marmoset-Biomedical Research Animal Model Applications and Common Spontaneous DiseasesHyo-Jeong Han, Sarah J Powers, Kathleen L Gabrielson
Comparative Medicine|August 28, 2015
Electrocardiographic Characterization of Cardiac Hypertrophy in Mice that Overexpress the ErbB2 Receptor Tyrosine KinasePolina Sysa-Shah, Lars L Sørensen, M Roselle Abraham, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|September 26, 2006
Validation of the use of long-term indwelling jugular catheters in a rat model of cardiotoxicityLynn M Wachtman, Michelle D Browning, Djahida Bedja, et al.
Cancer Immunology, Immunotherapy : CII|June 12, 2026
Donor-specific toxicity of copanlisib identified using immune-humanized miceRobyn E Becker, Jenny Résiliac, Kathleen L Gabrielson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 19, 2024
Combined, yet separate: cocktails of carriers (not drugs) for actinium-225 α-particle therapy of solid tumors expressing moderate-to-low levels of targetable markersRajiv Ranjit Nair, Aprameya Prasad, Omkar Bhatavdekar, et al.
Nature Medicine|December 15, 2010
Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expressionHyo-eun C Bhang, Kathleen L Gabrielson, John Laterra, et al.
Journal of Molecular and Cellular Cardiology|April 3, 2012
Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategiesYanti Octavia, Carlo G Tocchetti, Kathleen L Gabrielson, et al.
Experimental Biology and Medicine (Maywood, N.J.)|January 30, 2009
Cruciferous dithiolethione-mediated coordinated induction of total cellular and mitochondrial antioxidants and phase 2 enzymes in human primary cardiomyocytes: cytoprotection against oxidative/electrophilic stress and doxorubicin toxicityHong Zhu, Zhenquan Jia, Kequan Zhou, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|March 8, 2007
Spontaneous lesions in the reproductive tract and mammary gland of female non-human primatesTimothy K Cooper, Kathleen L Gabrielson
Comparative Medicine|September 16, 2022
Canine Idiopathic Arteriopathy, Appendicular Bone Infarcts, and Neoplastic Transformation of Bone Infarcts in 108 Dogs (<i>Canis lupus familiaris</i>)Isabel A Jimenez, Roy R Pool, Kathleen L Gabrielson
Toxicologic Pathology|May 10, 2022
The Common Marmoset-Biomedical Research Animal Model Applications and Common Spontaneous DiseasesHyo-Jeong Han, Sarah J Powers, Kathleen L Gabrielson
Comparative Medicine|August 28, 2015
Electrocardiographic Characterization of Cardiac Hypertrophy in Mice that Overexpress the ErbB2 Receptor Tyrosine KinasePolina Sysa-Shah, Lars L Sørensen, M Roselle Abraham, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|September 26, 2006
Validation of the use of long-term indwelling jugular catheters in a rat model of cardiotoxicityLynn M Wachtman, Michelle D Browning, Djahida Bedja, et al.
Cancer Immunology, Immunotherapy : CII|June 12, 2026
Donor-specific toxicity of copanlisib identified using immune-humanized miceRobyn E Becker, Jenny Résiliac, Kathleen L Gabrielson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 19, 2024
Combined, yet separate: cocktails of carriers (not drugs) for actinium-225 α-particle therapy of solid tumors expressing moderate-to-low levels of targetable markersRajiv Ranjit Nair, Aprameya Prasad, Omkar Bhatavdekar, et al.
Nature Medicine|December 15, 2010
Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expressionHyo-eun C Bhang, Kathleen L Gabrielson, John Laterra, et al.
Journal of Molecular and Cellular Cardiology|April 3, 2012
Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategiesYanti Octavia, Carlo G Tocchetti, Kathleen L Gabrielson, et al.
Experimental Biology and Medicine (Maywood, N.J.)|January 30, 2009
Cruciferous dithiolethione-mediated coordinated induction of total cellular and mitochondrial antioxidants and phase 2 enzymes in human primary cardiomyocytes: cytoprotection against oxidative/electrophilic stress and doxorubicin toxicityHong Zhu, Zhenquan Jia, Kequan Zhou, et al.
Pageof 8